
EVA Pharma and MedRight – HPM have signed a Memorandum of understanding (MoU) aimed at expanding the umbrella of patient support programs and delivering integrated medical services across a number of vital specialties.
The agreement focuses on making EVA Pharma’s patient support programs available to patients within the MedRight network, specifically in the areas of cardiology and metabolic health, immunology, oncology, and orthopedics and pain management.
Under the MoU, both companies commit to ensuring continuity of medical care: enrolled patients will continue to receive the benefits of the support programs until the end of their current treatment course.
Dr. Abram Wagih, Egypt Cluster Head of EVA Pharma, stated that this collaboration reflects the company’s commitment to facilitating patient access to high-quality medicines and providing extended healthcare. He added: “Our role is not limited to providing treatment options; it extends to supporting the entire healthcare system. This MoU will help raise the efficiency of physicians and case management teams at MedRight through ongoing medical training and education programs that keep pace with the latest scientific evidence. It represents integration among all entities working in the healthcare sector.”
For her part, Dr. Mary Gergis Said, CEO of MedRight - HPM for Healthcare Programs Management, said: “We are proud of this MoU, which brings together care management and the pharmaceutical industry to deliver real added value. It gives beneficiaries access to Patient Support Programs (PSPs) throughout their treatment journey and paves the way for expanding it toward Wellness Programs. We also look forward to this step being the beginning of a new phase of fruitful cooperation. Driven by our belief in integrated and innovative solutions, we are keen to build sustainable partnerships that elevate the services provided to our clients and meet their needs.”
The MoU includes strict institutional controls that prevent directing or obliging physicians to prescribe specific medicines and prohibit offering any financial incentives or gifts to medical staff, ensuring the full integrity of treatment decisions. The MoU also includes dedicated sections for patient data confidentiality and periodic review meetings between the two parties to ensure the collaboration’s objectives are achieved to the highest quality standards.
About EVA Pharma
EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products.
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies.
Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand.
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 40 countries worldwide. For more information, please visit: www.evapharma.com & https://evapharma.com/newsroom or follow us on Facebook, LinkedIn & Instagram
About MedRight - HPM
MedRight -HPM Group draws on roughly 13 years of experience in the Egyptian market. It began with MedRight for Medical Services and has grown to include specialized companies in medical insurance and healthcare programs management, with the aim of delivering integrated solutions that combine medical and administrative expertise with modern technology, in line with the highest standards of quality, efficiency, and governance.
MedRight - HPM is one of the Group’s companies, specializing in healthcare programs management services for institutions and insurance companies, including management of medical provider networks, medical approvals, claims, and monitoring of service quality and costs, while adhering to agreed service quality standards and Service Level Agreements (SLAs), ensuring fast response, operational efficiency, and a higher standard of services.
The company pays special attention to innovation and continuous development, building on its leadership in adopting modern technology solutions and digital transformation in healthcare management. It relies on an integrated technology ecosystem and digital operations that support process automation, enhance data accuracy, transparency, and cost control, and enable continuous monitoring of performance indicators and service quality, thereby improving the experience of clients and beneficiaries.
MedRight - HPM continues to invest in developing its systems, operational capabilities, and human resources to keep pace with rapid developments in the healthcare sector and strengthen its ability to deliver innovative and sustainable services that meet the needs of the Egyptian market.
We empower the fight for health and well being as a human right.
Subscribe for our latest news and updates
For adverse events reporting, please contact us on
PV.Report@evapharma.com